Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
This will be a randomized, double-blind (evaluator-blind), vehicle-controlled study of 50
enrolled subjects. Adult subjects (greater than 18 years old) who present with a mildly
infected diabetic foot ulcer (IDSA criteria) having full thickness (i.e., through the dermis
but not involving joint capsule, tendon, and bone). Subjects must also provide informed
consent and meet all other entry criteria to be enrolled and randomly assigned to receive
PluroGel N or PluroGel vehicle.